chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine, there was a blood drive at the clinic and she gave blood.  After she left there she went down to the clinic and had lunch, vegetable plate.  She went home and started feeling sick, and got some milk and went into the bathroom, drank 16 oz of milk and she felt a little faint.  As soon as she drank the milk she did not know what had happened and apparently fainted.  When she came to she had found that she had vomited up everything she had eaten and drank.  After that she came out of the bathroom and was feeling alright and laid down, and after that she was feeling alright.  She did not have any more episodes.  She has not called her doctor yet.    She has never had a reaction from a vaccine, no arm soreness and no reaction to any of the COVID vaccines.  Has never had any history of fainting in the past.
Patient received 3 vaccines. 5-7 minutes later, she had a vasovagal syncopal episode. She started feeling nauseous, sat down, and fell against her mother's shoulder.  Patient was given juice and a snack and recovered quickly. 5 minutes later, her symptoms resolved completely.
Hormonal changes with no other explanation. Extreme period bleeding and clotting (atypical for me), cystic acne on neck and back (atypical for me), extreme cramping (atypical for me). None of my normal menstrual symptoms were present - which are usually only limited to irritability, and occasional light cramping which ceases as soon as my flow starts. My periods have been irregular, stronger, and longer. I am experiencing clotting and severe pain.   I am currently on my second period since both doses. I?m am experiencing symptoms I have never or rarely experienced with my periods in adulthood, and most definitely have not experienced any of these symptoms in over 12 years (since pregnancy and child birth). I have kept  monthly records of my cycle for years, as I?ve anticipated changes as I age, but experienced no changes until I received the covid vaccine.
within the 15 of receiving injection patient started yarning and complaining of being thirsty, feeling light headed and sweaty. table was lowered in supine position - patient became limp and some what unresponsive. Treatment: epinephrine and 911 was called. BP at 5:00 was -  72/51 at 5:05 - 62/40 at 5:13  - 77/50 and 5:18 -  89/57 by the time EMS arrived. Patient transported to  Facility.
I received the Td vaccine on Friday, December 22, 2017, at approximately 5:30pm. Overnight, at aproximately 2:30 am, I awoke feeling very unwell with nausea, itching, body twitches and lightheaded while lying flat. I fell back asleep and woke up at approximately 8:30am, on December 23, 2017, with extreme fatigue, chills, itching, nausea, dry heaves, diarrhea, dizziness, strange sensation the left side of my face, reactivation of my otherwise quiet trigeminal neuralgia and neck sapsm. My heart rate was also in the 120s just lying still. I spent the day in bed taking Benadryl, Ibuprofen and lots of fluids. By Sunday, 12/24/17, I went to the ER and was later discharged.  Christmas Day, 12/25/17, I continued to experience all of the above with less diarrhea, and the addition of generalized lymph node and joint pain. Tuesday, 12/26/17, I was too ill to walk and called the Physician who prescribes my IVIG and my Husband wheeled me into his Office. I stayed at the Clinic for a few hours receiving I liter of N/S, Decadron 10 mg IV and Zofran 16mg IV. I left feeling much less nausea but with all the other concerns.  Later, the evening of 12/26/17,  my legs began to feel very wrong. They were weak and burning with tingling in feet working its way to the knees. I went to the ER and was hospitalized for a few days for what the Hospitalist told my Husband and I was an acute vaccine reaction and serum sickness.
The patient returned to the pharmacy in the afternoon of the day following the injection. A four inch area surrounding the injection site was inflamed with a rash that appeared to be shingles. The patient complained of pain, heat and irritation in the affected area. I recommended hydrocortisone cream, warm compresses and pain relievers.
Pt. arrived the hospital on 5/1/21 c/o SOB. Within a few hours, she went into cardiac arrest and was resuscitated. Pt. was placed on a Ventilator. She expired on 5/4/21.
felt bad; breathing problems; fatigue; flu like sympotoms; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad), RESPIRATION ABNORMAL (breathing problems), INFLUENZA LIKE ILLNESS (flu like sympotoms), PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 14-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like sympotoms). On 16-Feb-2021, the patient experienced RESPIRATION ABNORMAL (breathing problems) and FATIGUE (fatigue). On 21-Feb-2021, the patient experienced FEELING ABNORMAL (felt bad). At the time of the report, FEELING ABNORMAL (felt bad), RESPIRATION ABNORMAL (breathing problems), INFLUENZA LIKE ILLNESS (flu like sympotoms), PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medication reported.
The pt received his shots in 8/01, 10 days later, he woke up covered in red bumps; I took him to the ER to find out he had Rubella.
Vaccine administered from expired vial; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered from expired vial) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On 15-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered from expired vial). On 15-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered from expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant informations were reported. No Treatment informations were reported.
Adult patient received Engerix-B pediatric/ Underdose; Adult patient received Engerix-B pediatric; This case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a 41-year-old female patient who received HBV (Engerix B pediatric) (batch number ZP72S, expiry date 15th December 2024) for prophylaxis.   On 7th February 2023, the patient received the 1st dose of Engerix B pediatric. On 7th February 2023, unknown after receiving Engerix B pediatric, the patient experienced adult use of a child product and accidental underdose. On an unknown date, the outcome of the adult use of a child product and accidental underdose were unknown.   Additional Information: GSK receipt date: 13-FEB-2023 Reporter's comment: The medical Assistant reported that adult patient received by error Engerix-B pediatric formulation. The reporter consent to follow up by mail. Additional supportive information: The adult patient was given Engerix-B pediatric in error, which led to accidental underdose and adult use of a child product.
Only soreness for 24-48 hrs. No other problems until day 8 when area of injection became itchy, red, hot and hard. Size of my palm. Resolved in 36-48 hrs. with no medication or treatment. I did see my primary care MD as I was concerned about a possible cellulitis at the injection site but it was deemed a delayed hypersenstivity reaction instead. Had I been told that this was a possible side effect, I would not have gone to my doctor but I had never heard of this occurring with this vaccine.
multiple increased body aches; multiple increased fever and body aches; Initial information received on 06-Nov-2020 regarding an unsolicited valid non-serious case from a physician.  This case involves a 16 years old patient who experienced multiple increased body aches and fever (pyrexia)and body aches (pain), after receiving MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] and MENINGOCOCCAL VACCINE B RFHBPA/FHBPB [TRUMENBA].  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and suspect TRUMENBA not produced by Sanofi Pasteur (lot number and expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious multiple increased body aches (pyrexia) and body aches (pain) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and TRUMENBA.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  The outcome was not reported for the evens pyrexia and pain.  There will be no information on the batch number or this case.
pt recvd MMR vax 11AUG92 & 18AUG92 seen by MD w/t103.6 & sl rash, irritable; 20AUG92 seen again rash worse, diarrhea x 2;
March 8th:  After inj., floaters in eyes, slight dizziness, felt warm.  Water given, observation by staff approx 30min.  Nurse escorted me out of building for extra precautions.   April 9th: Stomach cramping, headache left side.  400mg IBU taken.  April 10th bi-lateral edema , lower legs, right sided headache. 400mg IBU taken and elevated legs. April 11th: slight stomach cramping returned, with excessive flatulence.  April 12th: Tingling in lower legs, edema diminished.
After five minutes after client took immunization, client became pale and faint. Immediately laid her on the examination table.  Client B/P was taken R arm 98/52.  Pulse regular.  Then client was given   a cup of water.  About ten seconds skin color became red and she felt better.  Client waited in the immunization room for 20 minutes.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2015, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. In 2016, the patient was treated at a hospital for a persistent and severe vesicular rash, which was diagnosed as herpes zoster. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Information has been received from a physician concerning a 26 year old female who on 31-JUL-2008 was vaccinated with the third 0.5 ml dose of GARDASIL. On 31-JUL-2008 the patient began to develop swelling of her face and her neck. The swelling caused the patient have difficulty with both breathing and talking. The patient also developed a red rash on her face and neck. The patient sought was hospitalized on 02-AUG-2008. A computed axial tomography (CT) scan showed enlarged salivary glands. Medical attention was sought via office visit. The patient had been treated with clindamycin and corticosteroids. After starting the clindamycin, the patient developed a rash on her chest. The patient was noted to be recovering. No product quality complaint was involved. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. There was no information about the patient's concomitant medications, allergies and pertinent medical history reported. On 24-JAN-2017, the patient was vaccinated with an improperly stored dose of ZOSTAVAX subcutaneously, in the posterior left arm, lot# reported as M035146, expiry date 26-JUL-2017 (dose was not reported). ZOSTAVAX was stored in the temperature higher than 5 Fahrenheit degrees but less than 14 Fahrenheit degrees for 4 hours and 20 minutes. Digital data logger was involved. No previous temperature excursion was performed. No adverse events were reported. Additional information has been requested.
PATIENT HAD INDURATION WARMTH AND LOCAL ITCHING FROM THE SHOULDER TO THE ELBOW.  NOT TENDER OR PAINFUL WITH MOVEMENT. NO FEVER
Patient noted side of tongue feeling "funny" in the morning.  Tongue began swelling affecting airway. Some facial swelling. Went to urgent care . Administered injectable steroid and epinephrine and sent via ambulance to ER.
4 to 5 patients received shot past 30-day use by date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 to 5 patients received shot past 30-day use by date) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 to 5 patients received shot past 30-day use by date). On 13-Oct-2021, EXPIRED PRODUCT ADMINISTERED (4 to 5 patients received shot past 30-day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported . No treatment medication was reported . Date the vial was initially stored in the refrigerator: 08Sep2021 Reporter stated that patient had no side effects.   This case was linked to MOD-2021-351064, MOD-2021-363707, MOD-2021-363709, MOD-2021-363709, MOD-2021-355809, MOD-2021-363703, MOD-2021-351064 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Oct-2021: Contains no new information.
Primary concern: Change in tongue taste of food and drink. Janssen-reported side effects of sore arm increased from 4/4-4/7 then subsided. Mild intermittent headache behind forehead began one minute after injection and continued 4/4-4/7. Fatigue onset 4/4 lasting thru 4/6. Then on 4/7 late morning I realized everything I ate and drank tasted differently by approximately 75%. This continued to this date (4/8) although now taste change is approximately 50%.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 74-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history included: "Gout BPH" (unspecified if ongoing), notes: Goutm BPH; "Hyperlipidemia" (unspecified if ongoing); "Gout" (unspecified if ongoing), notes: Goutm BPH. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Patient had rebound of COVID symptoms. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received treatment (oral) from 30Jun2022 to 04Jul2022.  Clinical course: The patient received vaccine. and The patient did not received other medication in two weeks.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the event Covid 19 and Drug Ineffective and the suspect drug cannot be excluded. The case will be reassessed once new information is available.
Pain tenderness in the shoulder, fatigue, headache, muscle and joint pain, chills, Dizziness and weakness.
Ax temp-102 @ 4pm following vax, gave Tempra again @ 10pm-Rt leg swollen "not" red & warm to touch-Tempra 1 1/2 t. given both times. 345 am on 7Feb91 pt had convulsion & was taken to hospital, mild T /w cold sx X 3 days /p episode
Report received, Parent confirmed child date of birth.  Client received a dose on 11/12/2021 at which the child was 4yrs old.
Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Fever-Medium, Systemic: Shortness of Breath-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Additional Details: Patient states symptoms began the day following second dose administration; advised patient to seek medical follow-up as symptoms reported included shortness of breath. Patient agreed stating they had already contacted their doctor but wanted to let us know as well to report the adverse effects.
This is a spontaneous report from a contactable healthcare professional. A patient of unspecified age and gender received PREVNAR 13, via an unspecified route of administration in 2015 at a single dose for immunization; and PNEUMOVAX 23, via an unspecified route of administration in 2014 at an unknown dose for immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient received 13-valent conjugate vaccine (diphtheria crm197 protein) 11 months after receiving PNEUMOVAX 23, one month shy of the one year recommendation (inappropriate schedule of vaccine administered). Information on the batch number has been requested.
RETINA VEIN OCCLUSION; This spontaneous report received from a patient via social media via a company representative concerned a patient of unspecified age, sex, race and ethnicity The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, administered on APR-2021 for prophylactic vaccination. (Dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On JUN-2021, the patient stated that, "I took the J&J shot back in April days before they pulled it off for the issues. Two months later I had a blood vein in my eye bust. Condition called retina vein occlusion. No more shots of any kind for me. I believe the shot caused it. My eye Dr. has been able to improve my sight with 4 needle medicine shots in my eye." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from retina vein occlusion. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211230354- JANSSEN COVID-19 VACCINE Ad26.COV2.S- Retina vein occlusion. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Myalgia Occasional p[alpitations; body aches and headaches at night and conitnued for two days Narrative:
face is bright red with prickly feeling; face is bright red with prickly feeling; This is a spontaneous report from Pfizer-sponsored Program from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that he got his first dose an hour ago (unspecified date), then his face was bright red with prickly feeling on an unspecified date. The outcome of the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report has been received from a physician concerning a child patient of unknown age and gender. The patient's concurrent conditions and pertinent medical history were not reported. On 02-JUN-2015 (reported as today), the patient was vaccinated with the third dose of improperly stored oral, ROTATEQ (lot # K016314, exp. date on 05-JUN-2016), (strength not provided), 2 ml, oral. There was no concomitant medication reported. No adverse effects were reported. Additional information is not expected, because the physician did not want to be contacted.
6 days after the show on 2/6 I began to notice a soreness in my left armpit and assumed it may be a lymph node gland. The 7th day I took a jacuzzi that night and afterwards noticed my armpit more swollen and my left arm near injection site very warm and sore to the touch. After going to bed my whole left arm seemed to hurt more and into my back of neck and shoulders. Took a Tylenol PM. During the night I also felt pain in my left lower thigh but when I did finally get up everything felt better and no leg pain. However I noticed about a nickel size bruise around the injection site and about 2 inches lower a patch of red skin about 4 times that size. Non itchy. All 3 days I took temperature and blood pressure which seemed close to normal.
To ER.  Deceased.  Details unavailable.  Coroners case.  Autopsy performed.  Information from Coroner - preliminary shows no cause of death.
Pain,erythema,weakness, difficulty raising arm Since that first vaccination I have had 3 boosters last beeing 4/2/2022 I continue to have pain at night when lying in bed in my Rt arm. I also have waekness and difficulty lifting it at tiimes when lying. MRI scheduled
Medical assistant calling to report a temperature excursion that occurred 8/14/2020 which involved the following products: GARDASIL9, PEDVAXHIB, RECOMBIVAX, ROTATEQ. Per caller, "it would be possible that at least 100 patients have received vaccines; This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies or concomitant medications were not reported.  On 27-AUG-2020, the patient was vaccinated with an improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally as prophylaxis (lot # 1660991 with expiration date 27-APR-2021) (strength and frequency were not reported) and with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0.5 ml as prophylaxis (lot # S036821 with expiration date 21-APR-2022) (strength, frequency, route of administration and anatomical location were not reported).  The improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) and haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced a temperature excursion of 35.4 Fahrenheit degrees (°F) for the time frame of 20 minutes without previous temperature excursions. It was confirmed that a digital data logger was involved.  This is one of several cases from the same reporter. ; Sender's Comments:  US-009507513-2009USA006106:
My arm hurts and I can't stretch it and I can't breathe or speak. I get very cold and very hot in the neck.